$ICPT INTERCEPT PHARMACEUTICALS, INC. Insider Trading Week 13/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. in week 13/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 0.00 | 4,868 | 0 | 34,074 | |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 0.00 | 4,868 | 0 | 435,166 | 430.3 K to 435.2 K (+1.13 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Option Exercise | M | 0.00 | 649 | 0 | 4,543 | |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Buy | M | 0.00 | 649 | 0 | 7,041 | 6.4 K to 7 K (+10.15 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,326 | 44,991 | 0 | |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 1,622 | 0 | 11,358 | |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 321.95 | 879 | 282,997 | 13,679 | 14.6 K to 13.7 K (-6.04 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 338.16 | 500 | 169,082 | 14,558 | 15.1 K to 14.6 K (-3.32 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 335.84 | 1,000 | 335,844 | 15,058 | 16.1 K to 15.1 K (-6.23 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 334.52 | 388 | 129,793 | 16,058 | 16.4 K to 16.1 K (-2.36 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 333.22 | 1,626 | 541,809 | 16,446 | 18.1 K to 16.4 K (-9.00 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 330.06 | 1,000 | 330,060 | 18,072 | 19.1 K to 18.1 K (-5.24 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,326 | 44,991 | 19,072 | 14.7 K to 19.1 K (+29.34 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 1,622 | 0 | 14,746 | 13.1 K to 14.7 K (+12.36 %) |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,298 | 0 | 9,087 | |
| Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 0.00 | 1,298 | 0 | 12,006 | 10.7 K to 12 K (+12.12 %) |